Freelance CRA- Oncology - Spain
Our Clients ambition is to support their clients by advancing the progress of their drug development projects, and over the past decade, they have grown to a point, where they can offer all the necessary end-to-end expertise and competences to achieve this. It has enabled them to partner with both biotech and pharmaceutical companies and assist them in navigating the drug development process and successfully bring their products to market. They have more than 150 highly-qualified staff, all with industry experience, offer expert consulting and operational services throughout the entire drug development process.
The tasks would be Regulatory/EC Management and Submissions, Site Management, Monitoring (just as in the NUT-2 trial)
The overall trial timelines would be: Start in April 2022 and end March 2025.
The FTE level needs to be confirmed but for the countries with more sites perhaps 0,3 FTE, less for UK with a lower number of sites.
The trial is a Phase 1/2 Study in Subjects with NTRK-Fusion-Positive Advanced or Metastatic Solid Tumors.
Oncology experience will be key.
For more information get in touch with: email@example.com